f-chemotactic peptide has been researched along with calcimycin in 1 studies
| Studies (f-chemotactic peptide) | Trials (f-chemotactic peptide) | Recent Studies (post-2010) (f-chemotactic peptide) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 79 | 0 | 4 | 11,946 | 40 | 444 |
| Protein | Taxonomy | f-chemotactic peptide (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonser, RW; Cuatrecasas, P; McConnell, RT; Siegel, MI | 1 |
1 other study(ies) available for f-chemotactic peptide and calcimycin
| Article | Year |
|---|---|
The lipoxygenase product, 5-hydroperoxy-arachidonic acid, augments chemotactic peptide-stimulated arachidonic acid release from HL60 granulocytes.
Topics: Arachidonic Acid; Arachidonic Acids; Calcimycin; Cell Line; Chemotaxis, Leukocyte; Granulocytes; Humans; Leukemia, Myeloid; Leukotrienes; Oligopeptides | 1982 |